Early research suggests it may influence appetite regulation, energy balance and metabolic health, making it an area of significant scientific interest
Originally developed for obesity treatment, it stimulates fat breakdown and inhibits fat accumulation, making it a powerful tool for fat loss and body composition improvement
Eli Lilly press release: ATTAIN-MAINTAIN Phase 3 results
This triple-action mechanism helps reduce appetite, increase energy expenditure, and improve insulin sensitivity
The retrospective cohort study analyzed 125,474 adults who initiated liraglutide, semaglutide, or tirzepatide to treat obesity or being overweight between 2018 and 2023
They are commonly used in provider-guided wellness programs designed to support consistency, balanced routines, and overall metabolic efficiency